Open AccessEfficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study
Author(s) -
Bowen Chen,
Lei Jin,
Haitao Zhao,
Jinghui Dong,
Zhen Zeng,
Yinyin Li,
Lingxiang Yu,
Lin Zhou,
Aiying Jia,
Yinying Lu,
Jiamin Cheng
Publication year - 2022
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s387254
Subject(s) - medicine , adverse effect , clinical endpoint , sorafenib , lenvatinib , clinical trial , oncology , hepatocellular carcinoma